Home › Companies › PACIRA BIOSCIENCES INC. › 2024-2025

PACIRA BIOSCIENCES INC. 2024-2025 Proxy Voting Records

Compiled from SEC Form N-PX filings and PACIRA BIOSCIENCES INC.’s Form 8-K, filed June 13, 2025 (Item 5.07 on EDGAR). Page generated October 18, 2026.

  • 7Reported items
  • 290Asset managers
  • 2,664Fund votes
  • June 10, 2025Meeting date

Results at a glance

Meeting of June 10, 2025: 6 items on PACIRA BIOSCIENCES INC.’s Form 8-K, filed June 13, 2025: 6 without a stated outcome.

Material dissent

Material dissent: a director nominee under 80% of the votes cast, say-on-pay under 70%, any other item the board put forward under 80%, or a shareholder proposal with more than 50%, on the company’s own Form 8-K tally. How this is decided

Proxy season: 2023-2024 2024-2025 2025-2026

Explore PACIRA BIOSCIENCES INC. in the interactive database Compare manager voting policies

Official 2024-2025 meeting results reported by PACIRA BIOSCIENCES INC.

These tallies are PACIRA BIOSCIENCES INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed June 13, 2025 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

PACIRA BIOSCIENCES INC. — official shareholder meeting results, meeting held June 10, 2025
Ballot itemForAgainst AbstainWithheldBroker non-votesSupport (of votes cast)Reported outcomeVoting standard
Elect Director: Marcelo Bigal 33,364,221---- 4,017,5878,909,022 89%Not verified—
Elect Director: Frank D. Lee 32,858,858---- 4,522,9508,909,022 88%Not verified—
Elect Director: Alethia Young 28,757,450---- 8,624,3588,909,022 77%Not verified—
2. Ratification of the appointment of KPMG LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025 40,022,569352,94720,917 ---- 99.1%Not verified—
3. Advisory vote to approve the compensation of the Company's named executive officers 14,752,82922,595,20233,777 --8,909,022 40%Not verified—
5. Approval of the Company's Amended and Restated 2011 Stock Incentive Plan 22,043,90215,317,58820,318 --8,909,022 59%Not verified—

Source: PACIRA BIOSCIENCES INC., Form 8-K, filed with the SEC on June 13, 2025 — read the filing on EDGAR.

How asset managers voted at the PACIRA BIOSCIENCES INC. 2024-2025 meeting

Each item below shows how the 290 asset managers that disclosed a PACIRA BIOSCIENCES INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of PACIRA BIOSCIENCES INC.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.

1. Elect Director: Alethia Young

Outcome not verifiedDIRECTOR ELECTIONSReported outcome: Not verified

Combines 3 wordings of this item as funds reported it.

77% Majority: yes · of votes cast

FOR 77%WITHHELD
FOR: 28,757,450WITHHELD: 8,624,358
Details: description as filed, official tally, votes by 89 asset managers

Description as filed by funds: Election of three Class II directors to our Board of Directors to serve until the 2028 annual meeting of stockholders and until their successors are duly elected and qualified: Alethia Young

PACIRA BIOSCIENCES INC.’s own tally for this item (“Elect Director: Alethia Young”): 28,757,450 for, 8,624,358 withheld, per its Form 8-K filed June 13, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 77% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 89 asset managers below reported 16,876,755 for, 2,110,850 withheld, 2,449 abstained.

FOR
FOR: 16,876,755ABSTAIN: 2,449WITHHOLD: 2,110,850
Largest asset managers voting on “Election of three Class II directors to our Board of Directors to serve until the 2028 annual meeting of stock” at PACIRA BIOSCIENCES INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard5,389,4230 172,256For
BlackRock4,964,8570 0233,675For
Fidelity1,133,5260 020,577For
American Century685,6990 00For
Pacer Funds Trust536,6160 00For
State Street2,0660 0522,386Withhold
IMPAX FUNDS SERIES TRUST I520,0270 00For
TIAA511,9810 00For
Charles Schwab00 0470,353Withhold
Dimensional00 0462,129Withhold
Columbia Threadneedle359,7980 00For
Invesco348,5440 00For
DWS257,1310 00For
EA Series Trust229,0570 00For
JPMorgan201,6120 00For
Nationwide128,8650 00For
SEI00 0128,110Withhold
Equitable73,6260 051,500Mixed
Victory Capital115,7450 00For
Jackson National79,7220 011,963Mixed
Northern Trust88,2500 00For
GuideStone79,5870 00For
QUANTITATIVE MASTER SERIES LLC78,4750 00For
AIG/SunAmerica74,9860 00For
Hartford74,8610 00For

Showing the 25 largest of 89 asset managers. See all 89 in the interactive database.

2. Elect Director: Frank D. Lee

Outcome not verifiedDIRECTOR ELECTIONSReported outcome: Not verified

Combines 3 wordings of this item as funds reported it.

88% Majority: yes · of votes cast

FOR 88%
FOR: 32,858,858WITHHELD: 4,522,950
Details: description as filed, official tally, votes by 89 asset managers

Description as filed by funds: Election of three Class II directors to our Board of Directors to serve until the 2028 annual meeting of stockholders and until their successors are duly elected and qualified: Frank D. Lee

PACIRA BIOSCIENCES INC.’s own tally for this item (“Elect Director: Frank D. Lee”): 32,858,858 for, 4,522,950 withheld, per its Form 8-K filed June 13, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 88% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 89 asset managers below reported 18,483,844 for, 503,768 withheld, 2,442 abstained.

FOR
FOR: 18,483,844ABSTAIN: 2,442WITHHOLD: 503,768
Largest asset managers voting on “Election of three Class II directors to our Board of Directors to serve until the 2028 annual meeting of stock” at PACIRA BIOSCIENCES INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard5,391,6860 100For
BlackRock5,198,5320 00For
Fidelity1,154,1030 00For
American Century685,6990 00For
Pacer Funds Trust536,6160 00For
State Street524,4520 00For
IMPAX FUNDS SERIES TRUST I520,0270 00For
TIAA511,9810 00For
Charles Schwab470,3530 00For
Dimensional00 0462,129Withhold
Columbia Threadneedle359,7980 00For
Invesco348,5440 00For
DWS257,1310 00For
EA Series Trust229,0570 00For
JPMorgan201,6120 00For
Nationwide128,8650 00For
SEI128,1100 00For
Equitable125,1260 00For
Victory Capital115,7450 00For
Jackson National79,7220 011,963Mixed
Northern Trust88,2500 00For
GuideStone79,5870 00For
QUANTITATIVE MASTER SERIES LLC78,4750 00For
AIG/SunAmerica74,9860 00For
Hartford74,8610 00For

Showing the 25 largest of 89 asset managers. See all 89 in the interactive database.

3. Elect Director: Marcelo Bigal

Outcome not verifiedDIRECTOR ELECTIONSReported outcome: Not verified

Combines 3 wordings of this item as funds reported it.

89% Majority: yes · of votes cast

FOR 89%
FOR: 33,364,221WITHHELD: 4,017,587
Details: description as filed, official tally, votes by 89 asset managers

Description as filed by funds: Election of three Class II directors to our Board of Directors to serve until the 2028 annual meeting of stockholders and until their successors are duly elected and qualified: Marcelo Bigal

PACIRA BIOSCIENCES INC.’s own tally for this item (“Elect Director: Marcelo Bigal”): 33,364,221 for, 4,017,587 withheld, per its Form 8-K filed June 13, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 89% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 89 asset managers below reported 17,879,433 for, 1,108,184 withheld, 2,438 abstained.

FOR
FOR: 17,879,433ABSTAIN: 2,438WITHHOLD: 1,108,184
Largest asset managers voting on “Election of three Class II directors to our Board of Directors to serve until the 2028 annual meeting of stock” at PACIRA BIOSCIENCES INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard5,391,6900 60For
BlackRock5,198,5320 00For
Fidelity1,154,1030 00For
American Century685,6990 00For
Pacer Funds Trust536,6160 00For
State Street2,0660 0522,386Withhold
IMPAX FUNDS SERIES TRUST I520,0270 00For
TIAA511,9810 00For
Charles Schwab470,3530 00For
Dimensional00 0462,129Withhold
Columbia Threadneedle359,7980 00For
Invesco348,5440 00For
DWS257,1310 00For
EA Series Trust229,0570 00For
JPMorgan201,6120 00For
Nationwide128,8650 00For
SEI128,1100 00For
Equitable73,6260 051,500Mixed
Victory Capital115,7450 00For
Jackson National79,7220 011,963Mixed
Northern Trust88,2500 00For
GuideStone79,5870 00For
QUANTITATIVE MASTER SERIES LLC78,4750 00For
AIG/SunAmerica74,9860 00For
Hartford74,8610 00For

Showing the 25 largest of 89 asset managers. See all 89 in the interactive database.

4. 5. Approval of the Company's Amended and Restated 2011 Stock Incentive Plan

Outcome not verifiedCOMPENSATIONReported outcome: Not verified

Combines 4 wordings of this item as funds reported it.

59% Majority: yes · of votes cast

FOR 59%AGAINST
FOR: 22,043,902AGAINST: 15,317,588
Details: description as filed, official tally, votes by 94 asset managers

Description as filed by funds: APPROVAL OF OUR AMENDED AND RESTATED 2011 STOCK INCENTIVE PLAN.

PACIRA BIOSCIENCES INC.’s own tally for this item (“5. Approval of the Company's Amended and Restated 2011 Stock Incentive Plan”): 22,043,902 for, 15,317,588 against, per its Form 8-K filed June 13, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 59% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 94 asset managers below reported 15,111,634 for, 4,046,572 against, 10,119 abstained.

FORAGAINST
FOR: 15,111,634AGAINST: 4,046,572ABSTAIN: 10,119
Largest asset managers voting on “APPROVAL OF OUR AMENDED AND RESTATED 2011 STOCK INCENTIVE PLAN.” at PACIRA BIOSCIENCES INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard5,375,66416,032 00For
BlackRock5,198,5320 00For
Fidelity1,146,7587,345 00For
American Century0685,699 00Against
Pacer Funds Trust0536,616 00Against
State Street523,770682 00For
IMPAX FUNDS SERIES TRUST I520,0270 00For
TIAA511,9810 00For
Charles Schwab470,3530 00For
Dimensional0462,129 00Against
Columbia Threadneedle0359,798 00Against
Invesco0348,544 00Against
DWS0257,131 00Against
EA Series Trust229,0570 00For
JPMorgan201,6120 00For
Simplify Exchange Traded Funds133,3470 00For
Nationwide1,322127,543 00Against
SEI128,1100 00For
Equitable73,62651,500 00Mixed
Victory Capital0115,745 00Against
Jackson National091,685 00Against
Northern Trust088,250 00Against
GuideStone079,587 00Against
QUANTITATIVE MASTER SERIES LLC78,4750 00For
AIG/SunAmerica074,986 00Against

Showing the 25 largest of 94 asset managers. See all 94 in the interactive database.

5. 3. Advisory vote to approve the compensation of the Company's named executive officers

Outcome not verifiedFund totals may overlapSECTION 14A SAY-ON-PAY VOTESReported outcome: Not verified

Combines 7 wordings of this item as funds reported it.

40% Majority: no · of votes cast

FOR 40%AGAINST
FOR: 14,752,829AGAINST: 22,595,202
Details: description as filed, official tally, votes by 289 asset managers

Description as filed by funds: Approval, on an advisory basis, of the compensation of our named executive officers.

PACIRA BIOSCIENCES INC.’s own tally for this item (“3. Advisory vote to approve the compensation of the Company's named executive officers”): 14,752,829 for, 22,595,202 against, per its Form 8-K filed June 13, 2025 (Item 5.07). FOR was not more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 40% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports: 91 asset managers voting on “Approval, on an advisory basis, of the compensation of our named executive officers.” at PACIRA BIOSCIENCES INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard5,369,47422,222 00For
BlackRock233,6754,964,857 00Against
Fidelity1,126,65527,448 00For
American Century0685,699 00Against
Pacer Funds Trust536,6160 00For
State Street523,1481,304 00For
IMPAX FUNDS SERIES TRUST I520,0270 00For
TIAA0511,981 00Against
Charles Schwab0470,353 00Against
Dimensional0462,129 00Against
Columbia Threadneedle0359,798 00Against
Invesco0348,544 00Against
DWS0257,131 00Against
EA Series Trust0229,057 00Against
JPMorgan201,6120 00For
Simplify Exchange Traded Funds133,3470 00For
Nationwide1,320127,545 00Against
SEI128,1100 00For
Equitable0125,126 00Against
Victory Capital0115,745 00Against
Jackson National79,72211,963 00Mixed
Northern Trust088,250 00Against
GuideStone079,587 00Against
QUANTITATIVE MASTER SERIES LLC078,475 00Against
AIG/SunAmerica074,986 00Against

Fund voting reports, all 91 managers: 9,411,777 for, 9,746,405 against, 10,119 abstained. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports: 221 asset managers voting on “Approval, on an advisory basis, of the compensation of our named executive officers.” at PACIRA BIOSCIENCES INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
BlackRock408,5201,568,080 00Mixed
State Street1,334,03323,251 00For
Alyeska Investment Group, L.P.01,285,660 00Against
Renaissance01,177,924 00Against
GEODE CAPITAL MANAGEMENT, LLC1,148,7760 00For
American Century0735,215 00Against
Invesco0535,721 00Against
Charles Schwab0529,644 00Against
IMPAX ASSET MANAGEMENT LLC520,0270 00For
Nuveen0518,482 00Against
BALYASNY ASSET MANAGEMENT L.P.509,9720 00For
J. Goldman & Co LP473,8130 00For
DE Shaw0435,843 00Against
Wellington421,1220 00For
JACOBS LEVY EQUITY MANAGEMENT, INC0370,521 00Against
Northern Trust0337,181 00Against
PARAMETRIC PORTFOLIO ASSOCIATES LLC0331,854 00Against
JPMorgan293,9550 00For
Goldman Sachs272,3350 00For
PRINCIPAL GLOBAL INVESTORS0268,416 00Against
MELLON INVESTMENTS Corp197,3920 00For
SEI186,3368,037 00For
RICE HALL JAMES & ASSOCIATES, LLC191,9030 00For
Dimensional0178,399 00Against
Vanguard167,3522,829 00For

Institutional-manager reports, all 221 managers: 7,015,053 for, 10,521,461 against, 5,765 abstained, 58,939 1 year. Showing the 25 largest; see all in the interactive database.

6. Advisory vote to approve the frequency of future advisory votes to approve the compensation of our named executive…

No official matchFund totals may overlapSECTION 14A SAY-ON-PAY VOTES

Combines 3 wordings of this item as funds reported it.

29% Fund and manager reports combined; may count the same shares twice · no official result

1 YEAR
Details: description as filed, votes by 278 asset managers

Description as filed by funds: Advisory vote to approve the frequency of future advisory votes to approve the compensation of our named executive officers.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice). The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

Fund voting reports: 87 asset managers voting on “Advisory vote to approve the frequency of future advisory votes to approve the compensation of our named execu” at PACIRA BIOSCIENCES INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard00 00--
BlackRock00 00--
Fidelity00 00--
American Century00 00--
Pacer Funds Trust00 00--
State Street00 00--
IMPAX FUNDS SERIES TRUST I00 00--
TIAA00 00--
Charles Schwab00 00--
Dimensional00 00--
Columbia Threadneedle00 00--
Invesco00 00--
DWS00 00--
EA Series Trust00 00--
JPMorgan00 00--
Nationwide00 00--
SEI00 00--
Equitable00 00--
Victory Capital00 00--
Jackson National00 00--
Northern Trust00 00--
QUANTITATIVE MASTER SERIES LLC00 00--
AIG/SunAmerica00 00--
Hartford00 00--
Lincoln Financial23,5010 00For

Fund voting reports, all 87 managers: 23,501 for, 4,354 abstained, 18,352,783 1 year, 493,918 3 year, 0 2 year. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports: 215 asset managers voting on “Advisory vote to approve the frequency of future advisory votes to approve the compensation of our named execu” at PACIRA BIOSCIENCES INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
BlackRock00 00--
State Street00 00--
Alyeska Investment Group, L.P.00 00--
Renaissance00 00--
GEODE CAPITAL MANAGEMENT, LLC00 00--
American Century00 00--
Invesco00 00--
Charles Schwab00 00--
IMPAX ASSET MANAGEMENT LLC00 00--
Nuveen00 00--
BALYASNY ASSET MANAGEMENT L.P.00 00--
J. Goldman & Co LP00 00--
DE Shaw00 00--
Wellington00 00--
JACOBS LEVY EQUITY MANAGEMENT, INC00 00--
Northern Trust00 00--
PARAMETRIC PORTFOLIO ASSOCIATES LLC00 00--
Goldman Sachs00 00--
PRINCIPAL GLOBAL INVESTORS00 00--
MELLON INVESTMENTS Corp00 00--
SEI00 00--
RICE HALL JAMES & ASSOCIATES, LLC00 00--
Dimensional00 00--
Vanguard00 00--
Connor, Clark & Lunn Investment Management Ltd.00 00--

Institutional-manager reports, all 215 managers: 1,107 for, 59,771 against, 8 abstained, 16,990,957 1 year, 219,740 3 year. Showing the 25 largest; see all in the interactive database.

7. 2. Ratification of the appointment of KPMG LLP as the Company's independent registered public accounting firm for the…

Outcome not verifiedAUDIT-RELATEDReported outcome: Not verified

Combines 4 wordings of this item as funds reported it.

99.1% Majority: yes · of votes cast

FOR 99.1%
FOR: 40,022,569AGAINST: 352,947
Details: description as filed, official tally, votes by 92 asset managers

Description as filed by funds: RATIFICATION OF THE APPOINTMENT OF KPMG LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2025.

PACIRA BIOSCIENCES INC.’s own tally for this item (“2. Ratification of the appointment of KPMG LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025”): 40,022,569 for, 352,947 against, per its Form 8-K filed June 13, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 99.1% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 92 asset managers below reported 18,890,236 for, 273,711 against, 4,354 abstained.

FOR
FOR: 18,890,236AGAINST: 273,711ABSTAIN: 4,354
Largest asset managers voting on “RATIFICATION OF THE APPOINTMENT OF KPMG LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCA” at PACIRA BIOSCIENCES INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard5,391,6951 00For
BlackRock5,198,5320 00For
Fidelity1,154,1030 00For
American Century685,6990 00For
Pacer Funds Trust536,6160 00For
State Street524,42032 00For
IMPAX FUNDS SERIES TRUST I520,0270 00For
TIAA511,9810 00For
Charles Schwab470,3530 00For
Dimensional462,1290 00For
Columbia Threadneedle359,7980 00For
Invesco348,5440 00For
DWS257,1310 00For
EA Series Trust0229,057 00Against
JPMorgan201,6120 00For
Simplify Exchange Traded Funds133,3470 00For
Nationwide128,8650 00For
SEI128,1100 00For
Equitable125,1260 00For
Victory Capital115,7450 00For
Jackson National91,6850 00For
Northern Trust88,2500 00For
GuideStone79,5870 00For
QUANTITATIVE MASTER SERIES LLC78,4750 00For
AIG/SunAmerica74,9860 00For

Showing the 25 largest of 92 asset managers. See all 92 in the interactive database.

Largest PACIRA BIOSCIENCES INC. shareholders voting in 2024-2025

Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 46,283,407 shares outstanding at the time of that meeting.

Fund voting reports: top PACIRA BIOSCIENCES INC. shareholders by shares voted on “Approval, on an advisory basis, of the compensation of our named executive officers.”, 2024-2025
#Asset manager % of shares outstanding
1Vanguard 11.65%
2BlackRock 11.23%
3Fidelity 2.49%
4American Century 1.48%
5Pacer Funds Trust 1.16%
6State Street 1.13%
7IMPAX FUNDS SERIES TRUST I 1.12%
8TIAA 1.11%
9Charles Schwab 1.02%
10Dimensional 1.00%
Institutional-manager reports: top PACIRA BIOSCIENCES INC. shareholders by shares voted on “Approval, on an advisory basis, of the compensation of our named executive officers.”, 2024-2025
#Asset manager % of shares outstanding
1BlackRock 4.27%
2State Street 2.93%
3Alyeska Investment Group, L.P. 2.78%
4Renaissance 2.55%
5GEODE CAPITAL MANAGEMENT, LLC 2.48%
6American Century 1.59%
7Invesco 1.16%
8Charles Schwab 1.14%
9IMPAX ASSET MANAGEMENT LLC 1.12%
10Nuveen 1.12%

Reported PACIRA BIOSCIENCES INC. holdings and ownership

As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row names its form.

PACIRA BIOSCIENCES INC. holdings and ownership disclosed for the 2024-2025 proxy season
Holder % outstanding Disclosure
BlackRock 16.54% 13F
Vanguard Group 11.33% 13F
Pacer US Small Cap Cash Cows ETF 7.04% 13G
Doma Perpetual Capital Management LLC 6.35% 13D
Pedro Escudero 6.35% 13D
Vanguard Portfolio Management 5.59% 13G
D.E. Shaw 4.89% 13F
Renaissance Technologies 4.84% 13F
Dimensional Fund Advisors 4.43% 13F
State Street 4.28% 13F

Percentages above are of 46,283,407 shares outstanding, as reported by PACIRA BIOSCIENCES INC. on its Form 10-Q dated March 31, 2025 (see the filing on EDGAR). This is the count contemporaneous with the 2024-2025 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from PACIRA BIOSCIENCES INC.’s 10-Q dated March 31, 2025. This page is a static snapshot rebuilt weekly on October 18, 2026; a live search always shows the current data.

At PACIRA BIOSCIENCES INC.'s shareholder meeting held June 10, 2025, in the 2024-2025 proxy season, 290 asset managers reported how they voted in their SEC Form N-PX filings, covering 2,664 separate fund positions. Their filings are grouped here into 7 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item on that ballot — Approval, on an advisory basis, of the compensation of our named executive officers. — FOR was 40% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is not more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: PACIRA BIOSCIENCES INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on June 13, 2025.

PACIRA BIOSCIENCES INC. proxy season coverage: 2023-2024 · 2024-2025 (this page) · 2025-2026.

Download data (CSV): ballot items · votes by manager · column guide.